Back Together Again!

After over a year and half working remote with a virtual connection, Nuvera was excited to get the squad back together in our office! With folks coming from all over it was great to reconnect with familiar faces and re-acclimate to the office life. It was also exciting to finally meet our newest team members in person and show them the Nuvera office. The team enjoyed the time to catch up, celebration piñata full of fun prizes and delicious food truck. We are looking forward to the next exciting team event!

ICYMI -From Good to Great

Nuvera’s own Greg Christianson and John Valdes hosted an informative webinar earlier this month which explored levels of maturity in patient support capabilities.

We are Excited to Have Emma Zhu Join the Nuvera Team!

Emma graduated from Indiana University with both M.B.A. degree in Financial Accounting and B.S. degree in Accounting at Kelley School of Business. Emma is passionate in problem solving and bringing solutions to clients. Throughout her school years, she had multiple internship experiences in public accounting firms and banks. She also helped Indiana University to develop an evergreen fund that aims providing ample support for research projects at university-wide level.

Emma is from Chengdu, China, where the city is famous for a leisure lifestyle and spicy food. Therefore, she indulges her free time in traveling, spotting new restaurants, hanging out with friends and playing Mahjong. Also, Emma has been very passionate in art since little. She is currently learning watercolor and sketching that hopefully one day, there are some works that are decent enough to be seen in public.

Motivation for Joining Nuvera

“I have always had the passion of helping people and wanted to provide help with my professional and technical skills. I enjoyed that my experience in public accounting and banks helped me gain the business side of the operations. Later in college, I have realized I want to contribute more to the industry and society and that is when I started to look into health care industry. I believe joining Nuvera gives me a chance of helping clients and patients but also brining on the business savvy into the solutions. Additionally, Nuvera has a great company culture that we are constantly looking out for each other to grow and learn. With that being said, I am very excited to join the team!”

Nuvera Welcomes Afolabi Oshinowo to our Growing Team!

Afolabi joined Nuvera right after graduating from Tuck School of Business. Prior to Business school, Afolabi was a physician in Nigeria where he provided healthcare services to troops of the Nigerian Army and their families. Afolabi earned his Medical Degree from the University of Lagos in Nigeria, and outside work, he loves to spend time with his family, read books, and listen to podcasts.

Motivation for Joining Nuvera

“I loved clinical practice as it gave me opportunities to provide quality care to patients individually. However, due to the inefficiencies of the healthcare system in Nigeria, providing healthcare services was quite challenging. My goal is to learn about the best practices in the business of healthcare and, in the long term, use those learnings to contribute to the development of healthcare systems in Nigerian.

The Nuvera mission of helping clients provide programs and resources for a seamless patient experience resonates with me. The culture at the firm fits aptly with mine and I look forward to helping build patient-centric solutions that will make a difference.”

The Final Chapter of Nuvera’ s Infographic Series on Autologous Cell Therapies: The Technology Ecosystem (Part 5)

Will your technology infrastructure enable the success of your #CellTherapy? In this final installment of Nuvera’s Autologous Cell Therapy (ACT) infographic series, we address the likely systems and databases that will connect your internal processes and stakeholders to deliver a seamless patient/HCP treatment experience.

When considering the breadth of both internal/external stakeholders, the myriad activities needing to be managed through ACT use, and the various data & materials that need to be readily available, the technology ecosystem to accomplish all of this quickly becomes overly complex. As companies prepare for the commercialization of their ACTs, we can’t urge them enough to get a head start on mapping what they want to accomplish and prioritizing which pieces come first. Our final infographic will help get you started by highlighting key concepts that will need to be addressed as you begin your design journey.

#pharmaceuticals #biotechnology #celltherapy #healthtech

Who We Are: Nuvera LLC is a strategic consulting team focused exclusively on the rare disease and specialty therapeutics with over 10 years in helping our specialty pharma/biotech clients design exceptional treatment support experiences.

Note on Printing this Infographic: The optimal printing size for this graphic is 11×17 inch paper.

Contact Us: CellandGene@Nuveracg.com

Considerations for the Order Management of Autologous Cell Therapies (Part 4 of Nuvera’s ACT Series)

How easy is it to order your #celltherapy? Unlike off-the-shelf products, Autologous Cell Therapies are made to order for each individual patient – successful   and seamless delivery will depend on your ability to map out and clearly understand all the complexities.

This fourth installment of our series focuses on several critical considerations manufacturers must keep in mind as they navigate the complex process of managing individual patient orders from before order placement until final product delivery. The image below can serve as a reference to stimulate thinking during planning & strategy discussions across Marketing, Operations, and Supply Chain & Manufacturing teams.

Who We Are: Nuvera LLC is a strategic consulting team focused exclusively on the rare disease and specialty therapeutics with over 10 years in helping our specialty pharma/biotech clients design exceptional treatment support experiences.

Note on Printing this Infographic: The optimal printing size for this graphic is 11×17 inch paper.

Contact Us: Cell&Gene@Nuveracg.com

Exploring the Stakeholders Involved with Enabling Autologous Cell Therapies (Part 3)

How well have you mapped the stakeholders and functions involved with enabling the successful order, delivery, and infusion of your ACT product? Unlike traditional specialty products, even more sophisticated specialty therapeutics, the range of stakeholder functions involved with ACTs are much more extensive.

  In our 3rd Infographic of a five part series, we layout the key stakeholder functions that will need to be addressed/incorporated in some way into your commercialization planning. Leveraging your potential customer stakeholder functions to then explore the varied needs existing across each can then also lead to the holistic development of your customer needs sets… and your ultimate customer engagement model.

Who We Are: Nuvera LLC is a strategic consulting team focused exclusively on the rare disease and specialty therapeutics with over 10 years in helping our specialty pharma/biotech clients design exceptional treatment support experiences.

Note on Printing this Infographic: The optimal printing size for this graphic is 11×17 inch paper.

Contact Us: CellandGene@Nuveracg.com

Exploring the Experience with Autologous Cell Therapies (Part 2)

What Experience are you Designing for your #Celltherapy? Nuvera’s second infographic in a series of five focuses on highlighting how the experiences of patients, referring physicians, treatment centers, and the cells themselves relate to each other.

Mapping the details associated with the end-to-end treatment experience with ACTs is essential for a manufacturer to zero in on issues that are not only the most critical but also those they are most qualified to solve for (vs. trying to solve for everything). Our ACT Treatment Experience infographic will help shed some light on important considerations as you undertake this effort.

The ACT Treatment Experience infographic provides a broad overview of some of the areas where a biopharma manufacturer can influence the various elemental journeys with examples of inflection points requiring intervention or support in some form from your organization. Stay tuned for our next infographic which revolves around the functions and stakeholders involved across the ACT experience.

Note on Printing this Infographic: The optimal printing size for this graphic is 11×17 inch paper.

Who We Are: Nuvera LLC is a strategic consulting team focused exclusively on the rare disease and specialty therapeutics with over 10 years in helping our specialty pharma/biotech clients design exceptional treatment support experiences.

Contact Us: CellandGene@Nuveracg.com

Introducing Nuvera’s Infographic Series on Autologous Cell Therapies (Part 1)

Commercializing a CAR-T or other #Celltherapy? Nuvera is excited to share a newly developed series touching upon several commercialization issues surrounding Autologous Cell Therapies (ACTs) based upon over six years of direct experience partnering with multiple ACT manufacturers in helping to bring these amazing therapies to market.

This first installment of our series introduces several key concepts across four key ACT concepts: 1) The complexities of the overall treatment experience, 2) the multitude of stakeholders to consider, 3) steps of managing an intricate product utilization process, and finally, 4) the robust technology ecosystem required to enable commercialization.

In the coming weeks, Nuvera will share more detailed infographics aligned to the four areas described above. In the meantime, this snapshot can help stimulate potential thinking and internal dialog around where your company may need to focus next.

Note on Printing this Infographic: The optimal printing size for this graphic is 11×17 inch paper.

Who We Are: Nuvera LLC is a strategic consulting team focused exclusively on the rare disease and specialty therapeutics with over 10 years in helping our specialty pharma/biotech clients design exceptional treatment support experiences.

Contact Us: CellandGene@nuveracg.com

Nuvera Shares Key Insights to Boost Patient Support Program Satisfaction and Utilization

Nuvera team members, Edward Gajewski and Jens Kulstad, hosted an informative webinar that leveraged insights gathered from over 2,000 HCPs and patients discussing where and how they learn about support and how it impacts patient satisfaction in today’s changing landscape.

We had a great turn out live but incase you missed the event we have provided the recorded conversation below and the key learnings.

  1. How to Improve Program Awareness – Understand channels and drivers for pharma support program awareness among HCPs
  2. Drive Satisfaction With COVID-19 – Learn more about the impact COVID-19 had on the industry and translatable learning to your program
  3. Create Persistent and Sustained Refinements – Discover ways to ensure ongoing & continuous support program improvements.